Distress and family functioning in oncogenetic counselling for hereditary and familial breast and/or ovarian cancers.
We conducted a psychological assessment during oncogenetic counseling for hereditary breast/ovarian cancer. Anxiety and depression were assessed with the HAD scale, and family functioning and satisfaction with FACES III. HAD was administered at baseline (t(1)), at risk communication (t(2)), at genetic test result communication, or at first surveillance in not tested subjects (t(3)); FACES III was administered at baseline only. We analysed a total of 185 questionnaires administered to the 37 subjects studied. Although not pathological, distress was significantly higher at t(2) and t(3) (p = 0.027 and p = 0.039, respectively). Health and marital status were significantly associated with distress. In a disease-free condition, anxiety was higher (p = 0.027) at t(2), and for single status, depression increased from t(1) to t(2) (p = 0.026). Families were perceived to be well functioning, and subjects were satisfied with their families. The data collected in this analysis could help to improve the quality of oncogenetic counselling in clinical practice.
Condello
C
C
Department of Molecular and Clinical Endocrinology and Oncology, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.
Gesuita
R
R
Pensabene
M
M
Spagnoletti
I
I
Capuano
I
I
Baldi
C
C
Carle
F
F
Contegiacomo
A
A
D001943:Breast Neoplasms / Q000235:genetics / Q000523:psychology*; D005190:Family / Q000523:psychology*; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000523:psychology*; D013315:Stress, Psychological
Psychol Bull. 1985 Sep;98(2):310-57
3901065
Genet Test. 2004 Spring;8(1):23-9
15140371
Am J Med Genet A. 2006 Oct 15;140(20):2198-206
16969872
Am J Med Genet. 2002 Aug 1;111(2):147-51
12210341
Eur J Cancer. 1998 Nov;34(12):1922-6
10023316
Am J Med Genet. 1998 Jan 6;75(1):62-74
9450860
Br J Cancer. 1994 Nov;70(5):934-8
7947100
Am J Med Genet. 1997 Jul 11;71(1):63-71
9215771
J Natl Cancer Inst. 1992 Jan 1;84(1):24-30
1738170
Fam Cancer. 2005;4(2):121-6
15951962
Br J Cancer. 1991 Aug;64(2):353-6
1892763
Am J Med Genet. 2000 Aug 14;93(4):257-63
10946349
Psychosomatics. 1999 Jan-Feb;40(1):64-9
9989123
Acta Oncol. 2003;42(4):276-86
12899498
Br J Cancer. 2004 Nov 15;91(10 ):1787-94
15505627
Psychooncology. 2005 Dec;14(12):1060-74
15937976
Psychooncology. 2004 Dec;13(12):893-7
15457540
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
6880820
JAMA. 1997 Mar 26;277(12):997-1003
9091675
Med J Aust. 2003 Jan 20;178(2):77-81
12526728
Ann Oncol. 2004 May;15(5):726-32
15111339
Semin Surg Oncol. 2000 Jun;18(4):333-8
10805955
Ann Oncol. 2005 Jul;16(7):1208-9
15870089
Psychooncology. 2006 Jul;15(7):595-603
16287209
Am J Med Genet. 2001 Jan 1;98(1):15-24
11426450
Genet Test. 2004 Fall;8(3):240-7
15727246
Support Care Cancer. 1999 May;7(3):121-7
10335929
Cancer Detect Prev. 1999;23(1):22-30
9892987
J Clin Oncol. 2002 Jul 15;20(14):3137-48
12118028
J Clin Oncol. 2005 Oct 1;23(28):7105-13
16192594
J Pers Soc Psychol. 1985 Apr;48(4):1024-32
3989671
BMJ. 1998 Feb 28;316(7132):693-6
9522800
Psychosom Med. 1999 Mar-Apr;61(2):181-7
10204971
J Genet Couns. 2005 Oct;14(5):349-63
16195942
Soc Sci Med. 2001 Dec;53(11):1513-24
11710426
Psychooncology. 2005 Jul;14(7):564-73
15543537
Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):304-13
12692104
Psychooncology. 2005 Jul;14(7):555-63
15543540
Am J Hum Genet. 2003 May;72(5):1117-30
12677558
Cancer Detect Prev. 1996;20(1):76-85
8907207